Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong

In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced im...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Denise Pui Chung, Wong, Ngai Sze, Wong, Bonnie C.K., Chan, Jacky M.C., Lee, Shui Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514347/
https://www.ncbi.nlm.nih.gov/pubmed/36048772
http://dx.doi.org/10.3201/eid2810.220691
_version_ 1784798254671593472
author Chan, Denise Pui Chung
Wong, Ngai Sze
Wong, Bonnie C.K.
Chan, Jacky M.C.
Lee, Shui Shan
author_facet Chan, Denise Pui Chung
Wong, Ngai Sze
Wong, Bonnie C.K.
Chan, Jacky M.C.
Lee, Shui Shan
author_sort Chan, Denise Pui Chung
collection PubMed
description In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection.
format Online
Article
Text
id pubmed-9514347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-95143472022-10-01 Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong Chan, Denise Pui Chung Wong, Ngai Sze Wong, Bonnie C.K. Chan, Jacky M.C. Lee, Shui Shan Emerg Infect Dis Research Letter In a cohort of persons living with HIV in Hong Kong, surrogate virus neutralization testing for COVID-19 yielded a median level of 89% after the third dose of an inactivated COVID-19 vaccine, compared with 37% after the second dose. These results support using a 3-dose primary series for enhanced immune protection. Centers for Disease Control and Prevention 2022-10 /pmc/articles/PMC9514347/ /pubmed/36048772 http://dx.doi.org/10.3201/eid2810.220691 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Chan, Denise Pui Chung
Wong, Ngai Sze
Wong, Bonnie C.K.
Chan, Jacky M.C.
Lee, Shui Shan
Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
title Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
title_full Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
title_fullStr Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
title_full_unstemmed Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
title_short Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
title_sort three-dose primary series of inactivated covid-19 vaccine for persons living with hiv, hong kong
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514347/
https://www.ncbi.nlm.nih.gov/pubmed/36048772
http://dx.doi.org/10.3201/eid2810.220691
work_keys_str_mv AT chandenisepuichung threedoseprimaryseriesofinactivatedcovid19vaccineforpersonslivingwithhivhongkong
AT wongngaisze threedoseprimaryseriesofinactivatedcovid19vaccineforpersonslivingwithhivhongkong
AT wongbonnieck threedoseprimaryseriesofinactivatedcovid19vaccineforpersonslivingwithhivhongkong
AT chanjackymc threedoseprimaryseriesofinactivatedcovid19vaccineforpersonslivingwithhivhongkong
AT leeshuishan threedoseprimaryseriesofinactivatedcovid19vaccineforpersonslivingwithhivhongkong

Ejemplares similares